• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 2 hours
In the last 6 hours
Better Value Stock: AbbVie or Viatris? The Motley Fool11:03 10-Apr-21
In the last 7 days
What Will JAK Inhibitor Safety Jitters Mean For Drug Sales? Scrip Pharma Intelligence23:15 7-Apr-21
Should You Buy AbbVie in April? The Motley Fool12:26 6-Apr-21
In the last month
AbbVie Declares Quarterly Dividend AbbVie (Press Release)21:16 27-Mar-21
Alvotech Disputes AbbVie’s Recent Allegations Business Wire (Press Release)14:57 25-Mar-21
AbbVie Accuses Alvotech of Trade Secret Piracy Center for Biosimilars19:45 24-Mar-21
Mr. Market Gives You A Discount On AbbVie Seeking Alpha20:05 17-Mar-21
AbbVie Shares Cross 5% Yield Mark Forbes19:49 17-Mar-21
FDA pushback on AbbVie drug raises more alarms for biotech Crain's Chicago Business17:19 17-Mar-21
AbbVie looks to sell $5 billion portfolio Crain's Chicago Business20:01 16-Mar-21
view more headlines
11 Apr 16:25

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.